PTCT · Ptc Therapeutics, Inc. · Analyst Estimates
$64.78
-0.18 (-0.28%)
At close · Sep 30
View the 10-K filed Feb 19, 2026
Return incl. dividend (before tax)
Customer concentration
— top 4 customers 10% of revenue
4 customers — 10% of revenue (2025)
“During 2025, four of our distributors each accounted for over 10% of our net product sales.”
Market Cap
$5.23B
Shares
83.46M
Volume · Sep 30
1.04M
Avg daily vol (3M)
1.29M
Analyst Estimates
Compare analyst forecasts for Ptc Therapeutics, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-22 07:28 UTC · Publication dates shown per estimate · 16 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
1.5
|
1.71
|
1.82
|
— |
1.59667
|
1.49
|
1.59667
|
1.31333
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
3
|
— | — | — | — |
1
|
0
|
2
|
0
|
|
Revenue
USD
Publication date not stated |
1190000000
|
1257807180
|
1300892750
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
13
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
2.25
|
2.67667
|
3.04
|
— |
2.5
|
3.08667
|
2.5
|
2.78333
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
3
|
— | — | — | — |
2
|
0
|
1
|
0
|
|
Revenue
USD
Publication date not stated |
1087300000
|
1376893440
|
1595920100
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
13
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
0.3
|
0.38
|
0.48
|
— |
0.31
|
0.53667
|
0.31
|
0.47333
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
3
|
— | — | — | — |
2
|
2
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
273700000
|
303882930
|
322095000
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
12
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
0.15
|
0.3
|
0.5
|
— |
0.24667
|
0.53333
|
0.24667
|
0.45667
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
3
|
— | — | — | — |
3
|
0
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
286800000
|
320501160
|
352288530
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
12
|
— | — | — | — | — | — | — | — |
Key facts
CIK
1070081
CUSIP
69366J200
13F (30d)
14 filings
11 filers
Visit website
Investor relations